Partner Antoinette Konski was quoted in an FDA Week article on March 13, 2014 titled, “Gene Patent Experts Disagree About Patent Office’s Post-Myriad Guide.” The article discusses how experts are split on new guidance from the U.S. Patent and Trademark Office outlining when products that use naturally occurring genetic materials are patentable following a Supreme Court decision invalidating patents on naturally occurring DNA. Konski was quoted saying, “The guidance does not provide clear examples of marked differences that relate to current technology.”
People
Related News
03 May 2024
In the News
Jeff Symons’ Move to Foley Featured in Press
Foley & Lardner LLP partner Jeff Symons is featured in legal press for his recent arrival to the firm
03 May 2024
In the News
Nathaniel Lacktman on Healthleaders Podcast– ‘We’re seeing maturity in the telemedicine market’
Foley & Lardner LLP partner Nathaniel Lacktman discussed the upcoming American Telemedicine Association’s annual conference, new developments in telemedicine and digital health, the regulatory context, and the prospects for the industry’s future
02 May 2024
In the News
Jennifer Hennessy on American Privacy Rights Act – ‘This law does have teeth’
Foley & Lardner LLP partner Jennifer Hennessy assesses the prospects of what could be the first federal data privacy law passed in the United States